Search results for " effect"

showing 10 items of 7524 documents

Cardiac arrhythmia induced by hypothermia in a cardiac model in vitro

2013

The neurological damage after cardiac arrest (CA) constitutes a big challenge of hospital discharge since years. The therapeutic hypothermia therapy (34°C-32°C) has shown its benefit to reduce cerebral oxygen demand and improve neurological outcomes after the cardiac arrest. Despite the fact that induced hypothermia after CA has been shown to increase the hospital survival rate, it can have many adverse effects, among which the cardiac arrhythmia generation represents an important part (up to 34%, according different clinical studies). Compared to studies in vivo, cardiac culture in vitro provides a better spatial resolution at cellular level, which could bring some insights of the mechanis…

medicine.medical_specialtybusiness.industryCardiac arrhythmiaHypothermiaIn vitroNeurological DamageIn vivoInternal medicineAnesthesiacardiovascular systemCardiologymedicineHospital dischargemedicine.symptomCardiology and Cardiovascular MedicineAdverse effectbusinessSurvival rateJournal of Electrocardiology
researchProduct

Possible Adverse Effects of Hyperventilation on rCBF during the Acute Phase of Total Proximal Occlusion of a Main Cerebral Artery

1969

Recent studies seem to favor a beneficial effect of hyperventilation (HV) in cases of cerebrovascular occlusion [1, 4] and brain trauma [2, 5]. On the other hand, it seems that, at least under certain circumstances, HV may exert an adverse effect upon cerebral blood flow and metabolism [3]. Since this question is not settled yet, it seems worthwhile to report briefly the present case of reversible total occlusion of the middle cerebral artery closely followed by successive rCBF studies (133Xe-gamma-clearance method), in which, during the acute phase, HV caused a latent ischemia to become manifest.

medicine.medical_specialtybusiness.industryCerebral arteriesIschemiamedicine.diseaseCerebral blood flowAnesthesiaInternal medicinemedicine.arteryHyperventilationMiddle cerebral arterymedicineCardiologyAnterior cerebral arterymedicine.symptomAdverse effectbusinessProximal occlusion
researchProduct

<tocheading>Original Article</tocheading>

1999

In this double-blind clinical trial 429 patients (217 terbinafine and 212 clotrimazole) were randomized to receive twice daily terbinafine 1% topical solution for 1 week followed by a vehicle application for 3 weeks, or 1% clotrimazole solution for 4 weeks. Patients were evaluated clinically and mycologically at baseline and then at weeks one, two, four (end of treatment), and eight (end of follow-up). To be evaluable the patient needed to have a positive culture for a dermatophyte and positive KOH microscopy and a clinical diagnosis of tinea pedis (interdigital type) at baseline. Effective treatment of tinea pedis was recorded in 181 of 217 (83%) of patients treated for 1 week with terbina…

medicine.medical_specialtybusiness.industryClotrimazoleDermatologyGeneral Medicinemedicine.disease_causemedicine.diseaseDermatologylaw.inventionClinical trialInfectious DiseasesRandomized controlled trialTolerabilitylawmedicineDermatophyteTerbinafinebusinessAdverse effectMycosismedicine.drugMycoses
researchProduct

Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy

2021

ABSTRACTObjectiveTo assess in adult spinal muscular atrophy (SMA) patients the construct validity and responsiveness of several outcome measures.MethodsPatients older than 15 years and followed-up at least for 6 months, between October 2015 and August 2020, with one motor function scale (Hammersmith Functional Motor Scale Expanded, HFMSE; Revised Upper Limb module, RULM) in five referral centers were included. Bedside functional scales (Egen Klassification, EK2; Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, ALSFRS-R) were also collected when available. Correlations and regression models were performed to evaluate the construct validity. The monthly slopes of change were use…

medicine.medical_specialtybusiness.industryConstruct validityRegression analysisSpinal muscular atrophymedicine.diseaseSMA*Physical medicine and rehabilitationmedicine.anatomical_structureRating scaleFloor effectmedicineUpper limbAmyotrophic lateral sclerosisbusiness
researchProduct

Evaluation of Safe and Effectiveness of an Injectable Solution Acid Deoxycholic Based for Reduction of Localized Adiposities

2018

Background:. The use of deoxycholic acid to reduce localized fat deposits is a procedure that has been in use for about 30 years. Its effectiveness as treatment is due to emulsification of phospholipids and therefore, solubilization of the biological membranes with resulting fat necrosis. The purpose of the study was to assess the effectiveness and the safety of an injectable solution containing sodium deoxycholtate 1.25% (DB125), used as intralipotherapy. Methods:. The effectiveness and safety of DB125 solution have been assessed with a multicentre observational prospective study carried out between February and October 2017. The 221 selected patients presented with various forms and degre…

medicine.medical_specialtybusiness.industryDeoxycholic acidlcsh:SurgeryMedical evaluationlcsh:RD1-811030230 surgerymedicine.diseaseSurgeryVery frequent030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistrymedicineOriginal ArticleSurgeryObservational studyFat necrosisAdverse effectProspective cohort studybusinessInjectable SolutionPlastic and Reconstructive Surgery - Global Open
researchProduct

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regime…

2013

Abstract Background:  Interleukin-17A has major proinflammatory activity in psoriatic lesional skin. Objectives:  Assess the efficacy and safety of secukinumab, a fully human IgG1κ monoclonal anti-interleukin-17A antibody, in moderate-to-severe plaque psoriasis in a phase II regimen-finding study. Methods:  404 patients were randomised to subcutaneous placebo (67 patients) or one of three secukinumab 150 mg induction regimens: Single (week 0; 66 patients), Early (weeks 0, 1, 2, 4; 133 patients), and Monthly (weeks 0, 4, 8; 138 patients). The primary outcome was ≥75% improvement from baseline Psoriasis Area and Severity Index (PASI) score at week 12. PASI 75 responders from active treatment …

medicine.medical_specialtybusiness.industryDermatologyPlaceboSurgeryDiscontinuationlaw.inventionRegimenRandomized controlled trialMaintenance therapyPsoriasis Area and Severity IndexlawInternal medicinemedicineSecukinumabbusinessAdverse effectBritish Journal of Dermatology
researchProduct

Free Radicals and Antioxidants in Physical Exercise

1998

The beneficial effects of exercise are well documented. Indeed, it ameliorates diabetes mellitus, improves the plasma lipid profile, increases bone density and may help to lose weight. However, as stated in the old medical saying “the beneficial effects of exercise are lost with exhaustion”. It has been known for some time that exhaustive exercise causes muscle soreness, induces an elevation of cytosolic enzyme activities in blood plasma and may be harmful. In the last decade a considerable amount of information concerning production of free radicals in exhaustive exercise has been obtained. An international symposium took place in Valencia, Spain in 1993 and a book was published on the sub…

medicine.medical_specialtybusiness.industryDiabetes mellitusPlasma lipidsPhysical therapyMedicinePhysical exercisebusinessmedicine.diseaseBeneficial effects
researchProduct

2021

Abstract Strong evidence suggests that endoplasmic reticulum stress plays a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS) through altered regulation of proteostasis. Robust preclinical findings demonstrated that guanabenz selectively inhibits endoplasmic reticulum stress-induced eIF2α-phosphatase, allowing misfolded protein clearance, reduces neuronal death and prolongs survival in in vitro and in vivo models. However, its safety and efficacy in patients with ALS are unknown. To address these issues, we conducted a multicentre, randomized, double-blind trial with a futility design. Patients with ALS who had displayed an onset of symptoms within the previous 18 mon…

medicine.medical_specialtybusiness.industryDiseasePlacebomedicine.diseaseRiluzoleInternal medicineBreathingMedicineNeurology (clinical)DosingAmyotrophic lateral sclerosisGuanabenzbusinessAdverse effectmedicine.drugBrain
researchProduct

Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?

2020

Abstract Objectives Daptomycin is a widely used antibiotic. Rhabdomyolysis related to daptomycin is one of the adverse effects of treatment, justifying the need for regular monitoring of muscle enzymes throughout treatment. Daptomycin may also lead to eosinophilic pneumonia. However, risk factors for this adverse reaction have not been identified and do not permit targeting of at-risk populations who could benefit from appropriate monitoring. Patients and methods Literature was reviewed for cases of daptomycin-induced eosinophilic pneumonia (DIEP), which that were compared to cases of patients without this adverse effect. Results Fifty patients with DIEP and 54 controls were identified. Age…

medicine.medical_specialtybusiness.industryDiseasemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesDaptomycinRisk FactorsInternal medicineDiabetes mellitusmedicineEosinophilic pneumoniaHumansDaptomycinRisk factorPulmonary EosinophiliaAdverse effectbusinessRhabdomyolysisPulmonary EosinophiliaLungmedicine.drugInfectious diseases now
researchProduct

Nondietary therapies for celiac disease.

2012

Currently, the only available therapy for celiac disease is strict lifelong adherence to a gluten-free diet (GFD). Although safe and effective, the GFD is not ideal. It is frequently expensive, of limited nutritional value, and not readily available in many countries. Consequently, a need exists for novel, nondietary therapies for celiac disease. Based on the current understanding of celiac disease pathogenesis, several potential targets of therapeutic intervention exist. These novel strategies provide promise of alternative, adjunctive treatment options but also raise important questions regarding safety, efficacy, and monitoring of long-term treatment effect.

medicine.medical_specialtybusiness.industryGastroenterologynutritional and metabolic diseasesDiseaseDisease pathogenesisdigestive system diseasesCeliac DiseaseInterferon γAdjunctive treatmentImmunologyMedicineHumansTreatment effectbusinessIntensive care medicineGastrointestinal endoscopy clinics of North America
researchProduct